PV Bulletin

Tag archive

Germany

Paul-Ehrlich-Institut · Germany · Updated Sep 29, 2026

New Insights on Pharmacovigilance Released in German Bulletin on Drug Safety

Awareness · Medium

PV teams should review and potentially update their workflows, particularly in signal management and communications in light of the Bulletin's recommendations and insights.

Signal ManagementRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, PV Quality Lead
Regulatory action: Regulators
Read impact brief
Paul-Ehrlich-Institut · Germany · Updated Sep 29, 2026

#MedSafetyWeek 2026 Campaign Emphasizes Reporting of Adverse Reactions

Awareness · Medium

PV teams should ensure that training on adverse reaction reporting is current and communicate the importance of the #MedSafetyWeek campaign. Update workflows and SOPs related to signal management and literature surveillance to reflect the emphasis on consistent documentation and timely reporting of suspected adverse reactions.

Signal ManagementLiterature SurveillanceQPPV
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: QPPV, Medical Safety Lead
Regulatory action: Latest
Read impact brief
Paul-Ehrlich-Institut · Germany · Updated Sep 29, 2026

Bulletin on Drug Safety – Current Edition 3/2026 Released by Paul-Ehrlich-Institut

Awareness · Medium

Teams should ensure compliance by reviewing and updating Standard Operating Procedures (SOPs) related to signal management and safety surveillance. Additionally, knowledge on PRAC recommendations from July to September 2026 must be integrated into ongoing assessments.

Signal ManagementICSRRegulatory Intelligence Lead
SOP Impact3 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, QPPV, Signal Management Lead
Regulatory action: Regulators
Read impact brief
Paul-Ehrlich-Institut · Germany · Updated Sep 29, 2026Translated from German

#MedSafetyWeek 2026 Focuses on Reporting Side Effects

Awareness · Medium

PV teams should update workflows to ensure compliance with the new reporting emphasis, implement clearer protocols for capturing adverse reaction reports, and communicate these obligations to healthcare professionals within their organizations.

Signal ManagementICSRQPPV
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: QPPV, Signal Management Lead, Regulatory Intelligence Lead
Regulatory action: Regulators
Read impact brief

Get updates for your PV role

Subscribe to impact-first pharmacovigilance updates. Select every role you want in your digest.

Digest roles: QPPV. Work email only